Connie Sánchez

10.7k total citations · 1 hit paper
210 papers, 8.6k citations indexed

About

Connie Sánchez is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Connie Sánchez has authored 210 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Cellular and Molecular Neuroscience, 83 papers in Pharmacology and 51 papers in Molecular Biology. Recurrent topics in Connie Sánchez's work include Treatment of Major Depression (81 papers), Neurotransmitter Receptor Influence on Behavior (78 papers) and Neuroscience and Neuropharmacology Research (62 papers). Connie Sánchez is often cited by papers focused on Treatment of Major Depression (81 papers), Neurotransmitter Receptor Influence on Behavior (78 papers) and Neuroscience and Neuropharmacology Research (62 papers). Connie Sánchez collaborates with scholars based in Denmark, United States and France. Connie Sánchez's co-authors include Alan L. Pehrson, John Hyttel, Eddi Meier, Francesc Artigas, Nasser Haddjeri, Karen E. Asin, Elena Dale, Jørn Arnt, Ove Wiborg and Maria Gulinello and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biological Psychiatry and Brain Research.

In The Last Decade

Connie Sánchez

208 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data

2014 400 citations Connie Sánchez, Francesc Artigas et al. profile →

Peers

Countries citing papers authored by Connie Sánchez

Since Specialization

Citations

This map shows the geographic impact of Connie Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Connie Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Connie Sánchez more than expected).

Fields of papers citing papers by Connie Sánchez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Connie Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Connie Sánchez. The network helps show where Connie Sánchez may publish in the future.

Co-authorship network of co-authors of Connie Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Connie Sánchez. A scholar is included among the top collaborators of Connie Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Connie Sánchez. Connie Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RELATIONSHIP OF MINIMALIST LOGO REDESIGN AND GENERATION Z’S PURCHASE INTENTION 2024 ·(unknown), (unknown), Connie Sánchez, (unknown), (unknown)	0
2	Characterization of pain-, anxiety-, and cognition-related behaviors in the complete Freund's adjuvant model of chronic inflammatory pain in Wistar–Kyoto rats 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Connie Sánchez, Karen L. Smith, John Kelly, Michelle Roche, David P. Finn	8
3	Changes in hypothalamic mu-opioid receptor expression following acute olanzapine treatment in female rats: Implications for feeding behavior 2023 ·Journal of Chemical Neuroanatomy ·(unknown), (unknown), Anne M. Landau, Connie Sánchez, Jens Randel Nyengaard	3
4	Spatial quantification of single cell mRNA and ligand binding of the kappa opioid receptor in the rat hypothalamus 2022 ·Journal of Chemical Neuroanatomy ·(unknown), (unknown), Anne M. Landau, Connie Sánchez, Jens Randel Nyengaard	3
5	Gene expression related to serotonergic and glutamatergic neurotransmission is altered in the flinders sensitive line rat model of depression: Effect of ketamine 2016 ·Synapse ·Kristian Gaarn du Jardin, Heidi Kaastrup Müller, Connie Sánchez, Gregers Wegener, Betina Elfving	15
6	Propriétés pharmacologiques de la vortioxetine et leurs conséquences pré-cliniques 2016 ·L Encéphale ·Denis J. David, Laurent Tritschler, Jean‐Philippe Guilloux, Alain M. Gardier, Connie Sánchez, Raphaël Gaillard	5
7	Subchronic vortioxetine treatment –but not escitalopram– enhances pyramidal neuron activity in the rat prefrontal cortex 2016 ·Neuropharmacology ·Maurizio S. Riga, Vicent Teruel‐Martí, Connie Sánchez, Pau Celada, Francesc Artigas	26
8	Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression 2016 ·Psychopharmacology ·Kristian Gaarn du Jardin, Nico Liebenberg, Heidi Kaastrup Müller, Betina Elfving, Connie Sánchez, Gregers Wegener	66
9	When ageing meets the blues: Are current antidepressants effective in depressed aged patients? 2015 ·Neuroscience & Biobehavioral Reviews ·Daniela Felice, Olivia F. O’Leary, John F. Cryan, Timothy G. Dinan, Alain M. Gardier, Connie Sánchez, Denis J. David	17
10	Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function 2015 ·CNS Spectrums ·Elena Dale, Alan L. Pehrson, (unknown), Yan Li, Steven C. Leiser, Gennady Smagin, Christina Kurre Olsen, Connie Sánchez	118
11	Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain Stimulation 2015 ·EBioMedicine ·Adeline Etiévant, (unknown), Cécile Betry, Erika Abrial, (unknown), (unknown), Hélène Scarna, Christelle Devader, Jean Mazella, Gregers Wegener, Connie Sánchez, Ouria Dkhissi‐Benyahya, Claude Gronfier, Véronique Coizet, Jean‐Martin Beaulieu, Pierre Blier, Guillaume Lucas, Nasser Haddjeri	47
12	A comparative review of escitalopram, paroxetine, and sertraline 2014 ·International Clinical Psychopharmacology ·Connie Sánchez, Elin Heldbo Reines, Stuart Montgomery	190
13	Poster Session I 2013 ·Neuropsychopharmacology ·Francesc Artigas, Maurizio S. Riga, Pau Celada, Connie Sánchez	2
14	Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: A potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism 2013 ·European Neuropsychopharmacology ·Kristian Gaarn du Jardin, (unknown), Connie Sánchez, Alan L. Pehrson	112
15	Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats 2013 ·Pharmacology Biochemistry and Behavior ·Arne Mørk, Liliana P. Montezinho, Silke Miller, (unknown), Niels Plath, Yan Li, Maria Gulinello, Connie Sánchez	124
16	Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5‐hydroxytryptamine reuptake inhibitors in mice 2008 ·British Journal of Pharmacology ·Mads Kreilgaard, David Glenn Smith, Lise T. Brennum, Connie Sánchez	37
17	The Pharmacology of Citalopram Enantiomers: The Antagonism by R‐Citalopram on the Effect of S‐Citalopram* 2006 ·Basic & Clinical Pharmacology & Toxicology ·Connie Sánchez	97
18	Agonistic behaviour of resident rats after acute and chronic treatment with S(+)- and R(-)-citalopram 2004 ·The International Journal of Neuropsychopharmacology ·Paul J. Mitchell, S. Hogg, Connie Sánchez	1
19	Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance 2003 ·European Journal of Pharmacology ·(unknown), Connie Sánchez, (unknown), Bjarke Ebert	39
20	Escitalopram (S-Enantiomer of Citalopram): Clinical Efficacy and Onset of Action Predicted from a Rat Model 2001 ·Pharmacology & Toxicology ·Stuart Montgomery, Henrik Loft, Connie Sánchez, Elin Heldbo Reines, Mariusz Papp	126

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact